ArticleEuropean heart journal. Case reports2026
Clinical and genetic characterization of homozygous
Article in European heart journal. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Familial hypercholesterolaemia (FH) is an inherited lipid disorder characterized by elevated low-density lipoprotein cholesterol (LDL-C) levels and increased risk of atherosclerotic cardiovascular disease. Despite its high prevalence, FH remains underdiagnosed and undertreated in many regions, particularly in low- and middle-income countries. Case summary: We describe two patients with homozygous FH (HoFH) diagnosed at a tertiary care centre using the Dutch Lipid Clinic Network diagnostic criteria, both presented with severe hypercholesterolaemia (LDL-C > 340 mg/dL) and tendon xanthomas, whereas early cardiovascular complications were evident only in Case 1. Genetic analysis confirmed pathogenic variants in Discussion: These cases highlight the genotypic and phenotypic heterogeneity of FH, with the c.1060+2T>G variant being reported for the first time in this region, thus expanding the known genetic spectrum of FH. Conclusion: This case series reinforces the importance of comprehensive clinical and genetic evaluation in patients with severe hypercholesterolaemia. Early diagnosis, intensified lipid-lowering strategies, and equitable access to advanced therapies are essential to improve outcomes in resource-constrained settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.